▶ 調査レポート

経皮ニコチンパッチの世界市場(~2026年)

• 英文タイトル:Global Transdermal Nicotine Patch Market Insights and Forecast to 2026

QYResearchが調査・発行した産業分析レポートです。経皮ニコチンパッチの世界市場(~2026年) / Global Transdermal Nicotine Patch Market Insights and Forecast to 2026 / MRC2-11QY10789資料のイメージです。• レポートコード:MRC2-11QY10789
• 出版社/出版日:QYResearch / 2020年11月25日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、114ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:医療、製薬
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Multi User¥865,800 (USD5,850)▷ お問い合わせ
  Enterprise License¥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料は経皮ニコチンパッチのグローバル市場について調査・分析したレポートです。種類別(7mg/24時間、14mg/24時間、21mg/24時間、10mg/16時間、15mg/16時間、25mg/16時間)市場規模、用途別(離脱クリニック、医療行為、個人喫煙者、その他)市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別経皮ニコチンパッチの競争状況、市場シェア
・世界の経皮ニコチンパッチ市場:種類別市場規模 2015年-2020年(7mg/24時間、14mg/24時間、21mg/24時間、10mg/16時間、15mg/16時間、25mg/16時間)
・世界の経皮ニコチンパッチ市場:種類別市場規模予測 2021年-2026年(7mg/24時間、14mg/24時間、21mg/24時間、10mg/16時間、15mg/16時間、25mg/16時間)
・世界の経皮ニコチンパッチ市場:用途別市場規模 2015年-2020年(離脱クリニック、医療行為、個人喫煙者、その他)
・世界の経皮ニコチンパッチ市場:用途別市場規模予測 2021年-2026年(離脱クリニック、医療行為、個人喫煙者、その他)
・北米の経皮ニコチンパッチ市場分析:米国、カナダ
・ヨーロッパの経皮ニコチンパッチ市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの経皮ニコチンパッチ市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の経皮ニコチンパッチ市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの経皮ニコチンパッチ市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):GlaxoSmithKline、Novartis、Johnson & Johnson、Perrigo Company、Mylan、Dr. Reddy's Laboratories、Rusan Pharma
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Market Analysis and Insights: Global Transdermal Nicotine Patch Market
The global Transdermal Nicotine Patch market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Transdermal Nicotine Patch Scope and Market Size
Transdermal Nicotine Patch market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Transdermal Nicotine Patch market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Transdermal Nicotine Patch market is segmented into
7mg/24hrs
14mg/24hrs
21mg/24hrs
10mg/16hrs
15mg/16hrs
25mg/16hrs

Segment by Application, the Transdermal Nicotine Patch market is segmented into
Withdrawal Clinics
Medical Practice
Individual Smokers
Others

Regional and Country-level Analysis
The Transdermal Nicotine Patch market is analysed and market size information is provided by regions (countries).
The key regions covered in the Transdermal Nicotine Patch market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Transdermal Nicotine Patch Market Share Analysis
Transdermal Nicotine Patch market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Transdermal Nicotine Patch business, the date to enter into the Transdermal Nicotine Patch market, Transdermal Nicotine Patch product introduction, recent developments, etc.

The major vendors covered:
GlaxoSmithKline
Novartis
Johnson & Johnson
Perrigo Company
Mylan
Dr. Reddy’s Laboratories
Rusan Pharma

レポート目次

1 Study Coverage
1.1 Transdermal Nicotine Patch Product Introduction
1.2 Market Segments
1.3 Key Transdermal Nicotine Patch Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Transdermal Nicotine Patch Market Size Growth Rate by Type
1.4.2 7mg/24hrs
1.4.3 14mg/24hrs
1.4.4 21mg/24hrs
1.4.5 10mg/16hrs
1.4.6 15mg/16hrs
1.4.7 25mg/16hrs
1.5 Market by Application
1.5.1 Global Transdermal Nicotine Patch Market Size Growth Rate by Application
1.5.2 Withdrawal Clinics
1.5.3 Medical Practice
1.5.4 Individual Smokers
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Transdermal Nicotine Patch Market Size, Estimates and Forecasts
2.1.1 Global Transdermal Nicotine Patch Revenue 2015-2026
2.1.2 Global Transdermal Nicotine Patch Sales 2015-2026
2.2 Global Transdermal Nicotine Patch, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Transdermal Nicotine Patch Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Transdermal Nicotine Patch Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Transdermal Nicotine Patch Competitor Landscape by Players
3.1 Transdermal Nicotine Patch Sales by Manufacturers
3.1.1 Transdermal Nicotine Patch Sales by Manufacturers (2015-2020)
3.1.2 Transdermal Nicotine Patch Sales Market Share by Manufacturers (2015-2020)
3.2 Transdermal Nicotine Patch Revenue by Manufacturers
3.2.1 Transdermal Nicotine Patch Revenue by Manufacturers (2015-2020)
3.2.2 Transdermal Nicotine Patch Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Transdermal Nicotine Patch Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Transdermal Nicotine Patch Revenue in 2019
3.2.5 Global Transdermal Nicotine Patch Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Transdermal Nicotine Patch Price by Manufacturers
3.4 Transdermal Nicotine Patch Manufacturing Base Distribution, Product Types
3.4.1 Transdermal Nicotine Patch Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Transdermal Nicotine Patch Product Type
3.4.3 Date of International Manufacturers Enter into Transdermal Nicotine Patch Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Transdermal Nicotine Patch Market Size by Type (2015-2020)
4.1.1 Global Transdermal Nicotine Patch Sales by Type (2015-2020)
4.1.2 Global Transdermal Nicotine Patch Revenue by Type (2015-2020)
4.1.3 Transdermal Nicotine Patch Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Transdermal Nicotine Patch Market Size Forecast by Type (2021-2026)
4.2.1 Global Transdermal Nicotine Patch Sales Forecast by Type (2021-2026)
4.2.2 Global Transdermal Nicotine Patch Revenue Forecast by Type (2021-2026)
4.2.3 Transdermal Nicotine Patch Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Transdermal Nicotine Patch Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Transdermal Nicotine Patch Market Size by Application (2015-2020)
5.1.1 Global Transdermal Nicotine Patch Sales by Application (2015-2020)
5.1.2 Global Transdermal Nicotine Patch Revenue by Application (2015-2020)
5.1.3 Transdermal Nicotine Patch Price by Application (2015-2020)
5.2 Transdermal Nicotine Patch Market Size Forecast by Application (2021-2026)
5.2.1 Global Transdermal Nicotine Patch Sales Forecast by Application (2021-2026)
5.2.2 Global Transdermal Nicotine Patch Revenue Forecast by Application (2021-2026)
5.2.3 Global Transdermal Nicotine Patch Price Forecast by Application (2021-2026)

6 North America
6.1 North America Transdermal Nicotine Patch by Country
6.1.1 North America Transdermal Nicotine Patch Sales by Country
6.1.2 North America Transdermal Nicotine Patch Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Transdermal Nicotine Patch Market Facts & Figures by Type
6.3 North America Transdermal Nicotine Patch Market Facts & Figures by Application

7 Europe
7.1 Europe Transdermal Nicotine Patch by Country
7.1.1 Europe Transdermal Nicotine Patch Sales by Country
7.1.2 Europe Transdermal Nicotine Patch Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Transdermal Nicotine Patch Market Facts & Figures by Type
7.3 Europe Transdermal Nicotine Patch Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Transdermal Nicotine Patch by Region
8.1.1 Asia Pacific Transdermal Nicotine Patch Sales by Region
8.1.2 Asia Pacific Transdermal Nicotine Patch Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Transdermal Nicotine Patch Market Facts & Figures by Type
8.3 Asia Pacific Transdermal Nicotine Patch Market Facts & Figures by Application

9 Latin America
9.1 Latin America Transdermal Nicotine Patch by Country
9.1.1 Latin America Transdermal Nicotine Patch Sales by Country
9.1.2 Latin America Transdermal Nicotine Patch Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Transdermal Nicotine Patch Market Facts & Figures by Type
9.3 Central & South America Transdermal Nicotine Patch Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Transdermal Nicotine Patch by Country
10.1.1 Middle East and Africa Transdermal Nicotine Patch Sales by Country
10.1.2 Middle East and Africa Transdermal Nicotine Patch Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Transdermal Nicotine Patch Market Facts & Figures by Type
10.3 Middle East and Africa Transdermal Nicotine Patch Market Facts & Figures by Application

11 Company Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Corporation Information
11.1.2 GlaxoSmithKline Description and Business Overview
11.1.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GlaxoSmithKline Transdermal Nicotine Patch Products Offered
11.1.5 GlaxoSmithKline Related Developments
11.2 Novartis
11.2.1 Novartis Corporation Information
11.2.2 Novartis Description and Business Overview
11.2.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Novartis Transdermal Nicotine Patch Products Offered
11.2.5 Novartis Related Developments
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Corporation Information
11.3.2 Johnson & Johnson Description and Business Overview
11.3.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Johnson & Johnson Transdermal Nicotine Patch Products Offered
11.3.5 Johnson & Johnson Related Developments
11.4 Perrigo Company
11.4.1 Perrigo Company Corporation Information
11.4.2 Perrigo Company Description and Business Overview
11.4.3 Perrigo Company Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Perrigo Company Transdermal Nicotine Patch Products Offered
11.4.5 Perrigo Company Related Developments
11.5 Mylan
11.5.1 Mylan Corporation Information
11.5.2 Mylan Description and Business Overview
11.5.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Mylan Transdermal Nicotine Patch Products Offered
11.5.5 Mylan Related Developments
11.6 Dr. Reddy’s Laboratories
11.6.1 Dr. Reddy’s Laboratories Corporation Information
11.6.2 Dr. Reddy’s Laboratories Description and Business Overview
11.6.3 Dr. Reddy’s Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Dr. Reddy’s Laboratories Transdermal Nicotine Patch Products Offered
11.6.5 Dr. Reddy’s Laboratories Related Developments
11.7 Rusan Pharma
11.7.1 Rusan Pharma Corporation Information
11.7.2 Rusan Pharma Description and Business Overview
11.7.3 Rusan Pharma Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Rusan Pharma Transdermal Nicotine Patch Products Offered
11.7.5 Rusan Pharma Related Developments
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Corporation Information
11.1.2 GlaxoSmithKline Description and Business Overview
11.1.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GlaxoSmithKline Transdermal Nicotine Patch Products Offered
11.1.5 GlaxoSmithKline Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Transdermal Nicotine Patch Market Estimates and Projections by Region
12.1.1 Global Transdermal Nicotine Patch Sales Forecast by Regions 2021-2026
12.1.2 Global Transdermal Nicotine Patch Revenue Forecast by Regions 2021-2026
12.2 North America Transdermal Nicotine Patch Market Size Forecast (2021-2026)
12.2.1 North America: Transdermal Nicotine Patch Sales Forecast (2021-2026)
12.2.2 North America: Transdermal Nicotine Patch Revenue Forecast (2021-2026)
12.2.3 North America: Transdermal Nicotine Patch Market Size Forecast by Country (2021-2026)
12.3 Europe Transdermal Nicotine Patch Market Size Forecast (2021-2026)
12.3.1 Europe: Transdermal Nicotine Patch Sales Forecast (2021-2026)
12.3.2 Europe: Transdermal Nicotine Patch Revenue Forecast (2021-2026)
12.3.3 Europe: Transdermal Nicotine Patch Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Transdermal Nicotine Patch Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Transdermal Nicotine Patch Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Transdermal Nicotine Patch Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Transdermal Nicotine Patch Market Size Forecast by Region (2021-2026)
12.5 Latin America Transdermal Nicotine Patch Market Size Forecast (2021-2026)
12.5.1 Latin America: Transdermal Nicotine Patch Sales Forecast (2021-2026)
12.5.2 Latin America: Transdermal Nicotine Patch Revenue Forecast (2021-2026)
12.5.3 Latin America: Transdermal Nicotine Patch Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Transdermal Nicotine Patch Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Transdermal Nicotine Patch Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Transdermal Nicotine Patch Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Transdermal Nicotine Patch Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Transdermal Nicotine Patch Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Transdermal Nicotine Patch Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Transdermal Nicotine Patch Market Segments
Table 2. Ranking of Global Top Transdermal Nicotine Patch Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Transdermal Nicotine Patch Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of 7mg/24hrs
Table 5. Major Manufacturers of 14mg/24hrs
Table 6. Major Manufacturers of 21mg/24hrs
Table 7. Major Manufacturers of 10mg/16hrs
Table 8. Major Manufacturers of 15mg/16hrs
Table 9. Major Manufacturers of 25mg/16hrs
Table 10. Global Transdermal Nicotine Patch Market Size Growth Rate by Application 2020-2026 (K Units)
Table 11. Global Transdermal Nicotine Patch Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 12. Global Transdermal Nicotine Patch Sales by Regions 2015-2020 (K Units)
Table 13. Global Transdermal Nicotine Patch Sales Market Share by Regions (2015-2020)
Table 14. Global Transdermal Nicotine Patch Revenue by Regions 2015-2020 (US$ Million)
Table 15. Global Transdermal Nicotine Patch Sales by Manufacturers (2015-2020) (K Units)
Table 16. Global Transdermal Nicotine Patch Sales Share by Manufacturers (2015-2020)
Table 17. Global Transdermal Nicotine Patch Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 18. Global Transdermal Nicotine Patch by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Transdermal Nicotine Patch as of 2019)
Table 19. Transdermal Nicotine Patch Revenue by Manufacturers (2015-2020) (US$ Million)
Table 20. Transdermal Nicotine Patch Revenue Share by Manufacturers (2015-2020)
Table 21. Key Manufacturers Transdermal Nicotine Patch Price (2015-2020) (USD/Unit)
Table 22. Transdermal Nicotine Patch Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Transdermal Nicotine Patch Product Type
Table 24. Date of International Manufacturers Enter into Transdermal Nicotine Patch Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Transdermal Nicotine Patch Sales by Type (2015-2020) (K Units)
Table 27. Global Transdermal Nicotine Patch Sales Share by Type (2015-2020)
Table 28. Global Transdermal Nicotine Patch Revenue by Type (2015-2020) (US$ Million)
Table 29. Global Transdermal Nicotine Patch Revenue Share by Type (2015-2020)
Table 30. Transdermal Nicotine Patch Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 31. Global Transdermal Nicotine Patch Sales by Application (2015-2020) (K Units)
Table 32. Global Transdermal Nicotine Patch Sales Share by Application (2015-2020)
Table 33. North America Transdermal Nicotine Patch Sales by Country (2015-2020) (K Units)
Table 34. North America Transdermal Nicotine Patch Sales Market Share by Country (2015-2020)
Table 35. North America Transdermal Nicotine Patch Revenue by Country (2015-2020) (US$ Million)
Table 36. North America Transdermal Nicotine Patch Revenue Market Share by Country (2015-2020)
Table 37. North America Transdermal Nicotine Patch Sales by Type (2015-2020) (K Units)
Table 38. North America Transdermal Nicotine Patch Sales Market Share by Type (2015-2020)
Table 39. North America Transdermal Nicotine Patch Sales by Application (2015-2020) (K Units)
Table 40. North America Transdermal Nicotine Patch Sales Market Share by Application (2015-2020)
Table 41. Europe Transdermal Nicotine Patch Sales by Country (2015-2020) (K Units)
Table 42. Europe Transdermal Nicotine Patch Sales Market Share by Country (2015-2020)
Table 43. Europe Transdermal Nicotine Patch Revenue by Country (2015-2020) (US$ Million)
Table 44. Europe Transdermal Nicotine Patch Revenue Market Share by Country (2015-2020)
Table 45. Europe Transdermal Nicotine Patch Sales by Type (2015-2020) (K Units)
Table 46. Europe Transdermal Nicotine Patch Sales Market Share by Type (2015-2020)
Table 47. Europe Transdermal Nicotine Patch Sales by Application (2015-2020) (K Units)
Table 48. Europe Transdermal Nicotine Patch Sales Market Share by Application (2015-2020)
Table 49. Asia Pacific Transdermal Nicotine Patch Sales by Region (2015-2020) (K Units)
Table 50. Asia Pacific Transdermal Nicotine Patch Sales Market Share by Region (2015-2020)
Table 51. Asia Pacific Transdermal Nicotine Patch Revenue by Region (2015-2020) (US$ Million)
Table 52. Asia Pacific Transdermal Nicotine Patch Revenue Market Share by Region (2015-2020)
Table 53. Asia Pacific Transdermal Nicotine Patch Sales by Type (2015-2020) (K Units)
Table 54. Asia Pacific Transdermal Nicotine Patch Sales Market Share by Type (2015-2020)
Table 55. Asia Pacific Transdermal Nicotine Patch Sales by Application (2015-2020) (K Units)
Table 56. Asia Pacific Transdermal Nicotine Patch Sales Market Share by Application (2015-2020)
Table 57. Latin America Transdermal Nicotine Patch Sales by Country (2015-2020) (K Units)
Table 58. Latin America Transdermal Nicotine Patch Sales Market Share by Country (2015-2020)
Table 59. Latin Americaa Transdermal Nicotine Patch Revenue by Country (2015-2020) (US$ Million)
Table 60. Latin America Transdermal Nicotine Patch Revenue Market Share by Country (2015-2020)
Table 61. Latin America Transdermal Nicotine Patch Sales by Type (2015-2020) (K Units)
Table 62. Latin America Transdermal Nicotine Patch Sales Market Share by Type (2015-2020)
Table 63. Latin America Transdermal Nicotine Patch Sales by Application (2015-2020) (K Units)
Table 64. Latin America Transdermal Nicotine Patch Sales Market Share by Application (2015-2020)
Table 65. Middle East and Africa Transdermal Nicotine Patch Sales by Country (2015-2020) (K Units)
Table 66. Middle East and Africa Transdermal Nicotine Patch Sales Market Share by Country (2015-2020)
Table 67. Middle East and Africa Transdermal Nicotine Patch Revenue by Country (2015-2020) (US$ Million)
Table 68. Middle East and Africa Transdermal Nicotine Patch Revenue Market Share by Country (2015-2020)
Table 69. Middle East and Africa Transdermal Nicotine Patch Sales by Type (2015-2020) (K Units)
Table 70. Middle East and Africa Transdermal Nicotine Patch Sales Market Share by Type (2015-2020)
Table 71. Middle East and Africa Transdermal Nicotine Patch Sales by Application (2015-2020) (K Units)
Table 72. Middle East and Africa Transdermal Nicotine Patch Sales Market Share by Application (2015-2020)
Table 73. GlaxoSmithKline Corporation Information
Table 74. GlaxoSmithKline Description and Major Businesses
Table 75. GlaxoSmithKline Transdermal Nicotine Patch Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 76. GlaxoSmithKline Product
Table 77. GlaxoSmithKline Recent Development
Table 78. Novartis Corporation Information
Table 79. Novartis Description and Major Businesses
Table 80. Novartis Transdermal Nicotine Patch Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 81. Novartis Product
Table 82. Novartis Recent Development
Table 83. Johnson & Johnson Corporation Information
Table 84. Johnson & Johnson Description and Major Businesses
Table 85. Johnson & Johnson Transdermal Nicotine Patch Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 86. Johnson & Johnson Product
Table 87. Johnson & Johnson Recent Development
Table 88. Perrigo Company Corporation Information
Table 89. Perrigo Company Description and Major Businesses
Table 90. Perrigo Company Transdermal Nicotine Patch Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 91. Perrigo Company Product
Table 92. Perrigo Company Recent Development
Table 93. Mylan Corporation Information
Table 94. Mylan Description and Major Businesses
Table 95. Mylan Transdermal Nicotine Patch Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 96. Mylan Product
Table 97. Mylan Recent Development
Table 98. Dr. Reddy's Laboratories Corporation Information
Table 99. Dr. Reddy's Laboratories Description and Major Businesses
Table 100. Dr. Reddy's Laboratories Transdermal Nicotine Patch Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 101. Dr. Reddy's Laboratories Product
Table 102. Dr. Reddy's Laboratories Recent Development
Table 103. Rusan Pharma Corporation Information
Table 104. Rusan Pharma Description and Major Businesses
Table 105. Rusan Pharma Transdermal Nicotine Patch Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 106. Rusan Pharma Product
Table 107. Rusan Pharma Recent Development
Table 108. Global Transdermal Nicotine Patch Sales Forecast by Regions (2021-2026) (K Units)
Table 109. Global Transdermal Nicotine Patch Sales Market Share Forecast by Regions (2021-2026)
Table 110. Global Transdermal Nicotine Patch Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 111. Global Transdermal Nicotine Patch Revenue Market Share Forecast by Regions (2021-2026)
Table 112. North America: Transdermal Nicotine Patch Sales Forecast by Country (2021-2026) (K Units)
Table 113. North America: Transdermal Nicotine Patch Revenue Forecast by Country (2021-2026) (US$ Million)
Table 114. Europe: Transdermal Nicotine Patch Sales Forecast by Country (2021-2026) (K Units)
Table 115. Europe: Transdermal Nicotine Patch Revenue Forecast by Country (2021-2026) (US$ Million)
Table 116. Asia Pacific: Transdermal Nicotine Patch Sales Forecast by Region (2021-2026) (K Units)
Table 117. Asia Pacific: Transdermal Nicotine Patch Revenue Forecast by Region (2021-2026) (US$ Million)
Table 118. Latin America: Transdermal Nicotine Patch Sales Forecast by Country (2021-2026) (K Units)
Table 119. Latin America: Transdermal Nicotine Patch Revenue Forecast by Country (2021-2026) (US$ Million)
Table 120. Middle East and Africa: Transdermal Nicotine Patch Sales Forecast by Country (2021-2026) (K Units)
Table 121. Middle East and Africa: Transdermal Nicotine Patch Revenue Forecast by Country (2021-2026) (US$ Million)
Table 122. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 123. Key Challenges
Table 124. Market Risks
Table 125. Main Points Interviewed from Key Transdermal Nicotine Patch Players
Table 126. Transdermal Nicotine Patch Customers List
Table 127. Transdermal Nicotine Patch Distributors List
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Transdermal Nicotine Patch Product Picture
Figure 2. Global Transdermal Nicotine Patch Sales Market Share by Type in 2020 & 2026
Figure 3. 7mg/24hrs Product Picture
Figure 4. 14mg/24hrs Product Picture
Figure 5. 21mg/24hrs Product Picture
Figure 6. 10mg/16hrs Product Picture
Figure 7. 15mg/16hrs Product Picture
Figure 8. 25mg/16hrs Product Picture
Figure 9. Global Transdermal Nicotine Patch Sales Market Share by Application in 2020 & 2026
Figure 10. Withdrawal Clinics
Figure 11. Medical Practice
Figure 12. Individual Smokers
Figure 13. Others
Figure 14. Transdermal Nicotine Patch Report Years Considered
Figure 15. Global Transdermal Nicotine Patch Market Size 2015-2026 (US$ Million)
Figure 16. Global Transdermal Nicotine Patch Sales 2015-2026 (K Units)
Figure 17. Global Transdermal Nicotine Patch Market Size Market Share by Region: 2020 Versus 2026
Figure 18. Global Transdermal Nicotine Patch Sales Market Share by Region (2015-2020)
Figure 19. Global Transdermal Nicotine Patch Sales Market Share by Region in 2019
Figure 20. Global Transdermal Nicotine Patch Revenue Market Share by Region (2015-2020)
Figure 21. Global Transdermal Nicotine Patch Revenue Market Share by Region in 2019
Figure 22. Global Transdermal Nicotine Patch Sales Share by Manufacturer in 2019
Figure 23. The Top 10 and 5 Players Market Share by Transdermal Nicotine Patch Revenue in 2019
Figure 24. Transdermal Nicotine Patch Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 25. Global Transdermal Nicotine Patch Sales Market Share by Type (2015-2020)
Figure 26. Global Transdermal Nicotine Patch Sales Market Share by Type in 2019
Figure 27. Global Transdermal Nicotine Patch Revenue Market Share by Type (2015-2020)
Figure 28. Global Transdermal Nicotine Patch Revenue Market Share by Type in 2019
Figure 29. Global Transdermal Nicotine Patch Market Share by Price Range (2015-2020)
Figure 30. Global Transdermal Nicotine Patch Sales Market Share by Application (2015-2020)
Figure 31. Global Transdermal Nicotine Patch Sales Market Share by Application in 2019
Figure 32. Global Transdermal Nicotine Patch Revenue Market Share by Application (2015-2020)
Figure 33. Global Transdermal Nicotine Patch Revenue Market Share by Application in 2019
Figure 34. North America Transdermal Nicotine Patch Sales Growth Rate 2015-2020 (K Units)
Figure 35. North America Transdermal Nicotine Patch Revenue Growth Rate 2015-2020 (US$ Million)
Figure 36. North America Transdermal Nicotine Patch Sales Market Share by Country in 2019
Figure 37. North America Transdermal Nicotine Patch Revenue Market Share by Country in 2019
Figure 38. U.S. Transdermal Nicotine Patch Sales Growth Rate (2015-2020) (K Units)
Figure 39. U.S. Transdermal Nicotine Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Canada Transdermal Nicotine Patch Sales Growth Rate (2015-2020) (K Units)
Figure 41. Canada Transdermal Nicotine Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. North America Transdermal Nicotine Patch Market Share by Type in 2019
Figure 43. North America Transdermal Nicotine Patch Market Share by Application in 2019
Figure 44. Europe Transdermal Nicotine Patch Sales Growth Rate 2015-2020 (K Units)
Figure 45. Europe Transdermal Nicotine Patch Revenue Growth Rate 2015-2020 (US$ Million)
Figure 46. Europe Transdermal Nicotine Patch Sales Market Share by Country in 2019
Figure 47. Europe Transdermal Nicotine Patch Revenue Market Share by Country in 2019
Figure 48. Germany Transdermal Nicotine Patch Sales Growth Rate (2015-2020) (K Units)
Figure 49. Germany Transdermal Nicotine Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. France Transdermal Nicotine Patch Sales Growth Rate (2015-2020) (K Units)
Figure 51. France Transdermal Nicotine Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. U.K. Transdermal Nicotine Patch Sales Growth Rate (2015-2020) (K Units)
Figure 53. U.K. Transdermal Nicotine Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Italy Transdermal Nicotine Patch Sales Growth Rate (2015-2020) (K Units)
Figure 55. Italy Transdermal Nicotine Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Russia Transdermal Nicotine Patch Sales Growth Rate (2015-2020) (K Units)
Figure 57. Russia Transdermal Nicotine Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Europe Transdermal Nicotine Patch Market Share by Type in 2019
Figure 59. Europe Transdermal Nicotine Patch Market Share by Application in 2019
Figure 60. Asia Pacific Transdermal Nicotine Patch Sales Growth Rate 2015-2020 (K Units)
Figure 61. Asia Pacific Transdermal Nicotine Patch Revenue Growth Rate 2015-2020 (US$ Million)
Figure 62. Asia Pacific Transdermal Nicotine Patch Sales Market Share by Region in 2019
Figure 63. Asia Pacific Transdermal Nicotine Patch Revenue Market Share by Region in 2019
Figure 64. China Transdermal Nicotine Patch Sales Growth Rate (2015-2020) (K Units)
Figure 65. China Transdermal Nicotine Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Japan Transdermal Nicotine Patch Sales Growth Rate (2015-2020) (K Units)
Figure 67. Japan Transdermal Nicotine Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. South Korea Transdermal Nicotine Patch Sales Growth Rate (2015-2020) (K Units)
Figure 69. South Korea Transdermal Nicotine Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. India Transdermal Nicotine Patch Sales Growth Rate (2015-2020) (K Units)
Figure 71. India Transdermal Nicotine Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Australia Transdermal Nicotine Patch Sales Growth Rate (2015-2020) (K Units)
Figure 73. Australia Transdermal Nicotine Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Taiwan Transdermal Nicotine Patch Sales Growth Rate (2015-2020) (K Units)
Figure 75. Taiwan Transdermal Nicotine Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Indonesia Transdermal Nicotine Patch Sales Growth Rate (2015-2020) (K Units)
Figure 77. Indonesia Transdermal Nicotine Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Thailand Transdermal Nicotine Patch Sales Growth Rate (2015-2020) (K Units)
Figure 79. Thailand Transdermal Nicotine Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Malaysia Transdermal Nicotine Patch Sales Growth Rate (2015-2020) (K Units)
Figure 81. Malaysia Transdermal Nicotine Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Philippines Transdermal Nicotine Patch Sales Growth Rate (2015-2020) (K Units)
Figure 83. Philippines Transdermal Nicotine Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Vietnam Transdermal Nicotine Patch Sales Growth Rate (2015-2020) (K Units)
Figure 85. Vietnam Transdermal Nicotine Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Asia Pacific Transdermal Nicotine Patch Market Share by Type in 2019
Figure 87. Asia Pacific Transdermal Nicotine Patch Market Share by Application in 2019
Figure 88. Latin America Transdermal Nicotine Patch Sales Growth Rate 2015-2020 (K Units)
Figure 89. Latin America Transdermal Nicotine Patch Revenue Growth Rate 2015-2020 (US$ Million)
Figure 90. Latin America Transdermal Nicotine Patch Sales Market Share by Country in 2019
Figure 91. Latin America Transdermal Nicotine Patch Revenue Market Share by Country in 2019
Figure 92. Mexico Transdermal Nicotine Patch Sales Growth Rate (2015-2020) (K Units)
Figure 93. Mexico Transdermal Nicotine Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Brazil Transdermal Nicotine Patch Sales Growth Rate (2015-2020) (K Units)
Figure 95. Brazil Transdermal Nicotine Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Argentina Transdermal Nicotine Patch Sales Growth Rate (2015-2020) (K Units)
Figure 97. Argentina Transdermal Nicotine Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Latin America Transdermal Nicotine Patch Market Share by Type in 2019
Figure 99. Latin America Transdermal Nicotine Patch Market Share by Application in 2019
Figure 100. Middle East and Africa Transdermal Nicotine Patch Sales Growth Rate 2015-2020 (K Units)
Figure 101. Middle East and Africa Transdermal Nicotine Patch Revenue Growth Rate 2015-2020 (US$ Million)
Figure 102. Middle East and Africa Transdermal Nicotine Patch Sales Market Share by Country in 2019
Figure 103. Middle East and Africa Transdermal Nicotine Patch Revenue Market Share by Country in 2019
Figure 104. Turkey Transdermal Nicotine Patch Sales Growth Rate (2015-2020) (K Units)
Figure 105. Turkey Transdermal Nicotine Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Saudi Arabia Transdermal Nicotine Patch Sales Growth Rate (2015-2020) (K Units)
Figure 107. Saudi Arabia Transdermal Nicotine Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. U.A.E Transdermal Nicotine Patch Sales Growth Rate (2015-2020) (K Units)
Figure 109. U.A.E Transdermal Nicotine Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. Middle East and Africa Transdermal Nicotine Patch Market Share by Type in 2019
Figure 111. Middle East and Africa Transdermal Nicotine Patch Market Share by Application in 2019
Figure 112. North America Transdermal Nicotine Patch Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 113. North America Transdermal Nicotine Patch Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Europe Transdermal Nicotine Patch Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 115. Europe Transdermal Nicotine Patch Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Asia Pacific Transdermal Nicotine Patch Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 117. Asia Pacific Transdermal Nicotine Patch Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Latin America Transdermal Nicotine Patch Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 119. Latin America Transdermal Nicotine Patch Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Middle East and Africa Transdermal Nicotine Patch Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 121. Middle East and Africa Transdermal Nicotine Patch Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Porter's Five Forces Analysis
Figure 123. Channels of Distribution
Figure 124. Distributors Profiles
Figure 125. Bottom-up and Top-down Approaches for This Report
Figure 126. Data Triangulation
Figure 127. Key Executives Interviewed